ADHD drugs and cardiovascular risk

Article Abstract:

The Food and Drug Administration (FDA) has recommended a 'black box' warning describing the cardiovascular risks of stimulant drugs used to treat attention deficit-hyperactivity disorder (ADHD), as the sympathomimetic agents in these drugs substantially increase the heart rate and blood pressure. However, medical practitioners have sought to emphasize more selective and restrictive use of these drugs, while increasing awareness of potential hazards.

Pharmaceutical Preparation Manufacturing, Management dynamics, Pharmaceutical preparations, Stimulant Preparations, Management, Company business management, United States. Food and Drug Administration, Attention-deficit hyperactivity disorder, Attention deficit hyperactivity disorder, Stimulants, Central nervous system stimulants

---

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

Article Abstract:

A randomized trial was conducted to assess the safety of valdecoxib and its intravenous prodrug parecoxib after it involved risk following the coronary-artery bypass grafting (CABG). The use of parecoxib and valdecoxib after CABG was found to be associated with an increased incidence of cardiovascular events aroused serious concern about the use of these drugs in such circumstances.

Science & research, Research, Parecoxib (Medication), Valdecoxib (Medication)

---

Cardiovascular events during World cup soccer

Article Abstract:

A study to examine the relation between emotional stress and the incidence of cardiovascular events during World cup soccer of 2006 is conducted. Results indicate that viewing a stressful soccer match more than doubles the risk of an acute cardiovascular event.

Psychological aspects, Health aspects, Competitions, Stress (Psychology), Soccer players, Soccer, Clinical report

Similar abstracts:

• Abstracts: Cystatin C and the risk of death and cardiovascular events among elderly persons. Spinal-fusion surgery- the case for restraint
• Abstracts: DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer. EGFR mutation and resistance of non-small-cell lung cancer to Gefitinib
• Abstracts: Road service: Which car is right for your family? Family cars: steering you in the right direction. Child's ultimate guide to family cars
• Abstracts: Positive thinking. Using simulation to prepare students for their qualified role. 'These awards bring national recognition'
• Abstracts: Tuberculosis treatment: Managing non-adherence. Cystic fibrosis. Wound infection

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.